These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 18204172
1. Antibody response to influenza vaccination in patients suffering from asthma. Romanowska M, Rybicka K, Nowak I, Józefczuk J, Zycinska K, Radzikowski A, Brydak LB. J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):583-9. PubMed ID: 18204172 [Abstract] [Full Text] [Related]
2. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Brydak LB, Machała M, Centkowski P, Warzocha K, Biliński P. Vaccine; 2006 Nov 10; 24(44-46):6620-3. PubMed ID: 16870313 [Abstract] [Full Text] [Related]
3. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study. Brydak LB, Romanowska M, Nowak I, Ciszewski A, Bilińska ZT. Med Sci Monit; 2009 Jul 10; 15(7):PH85-91. PubMed ID: 19564837 [Abstract] [Full Text] [Related]
4. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL. Pediatrics; 2007 Jun 10; 119(6):1076-82. PubMed ID: 17545373 [Abstract] [Full Text] [Related]
5. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T. Scand J Urol Nephrol; 2003 Jun 10; 37(1):71-6. PubMed ID: 12745749 [Abstract] [Full Text] [Related]
6. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730 [Abstract] [Full Text] [Related]
7. Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis. Zycinska K, Romanowska M, Nowak I, Rybicka K, Wardyn KA, Brydak LB. J Physiol Pharmacol; 2007 Nov 17; 58 Suppl 5(Pt 2):819-28. PubMed ID: 18204196 [Abstract] [Full Text] [Related]
8. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol; 2004 Apr 17; 113(4):717-24. PubMed ID: 15100679 [Abstract] [Full Text] [Related]
9. Specific antibody response after influenza immunization in systemic lupus erythematosus. Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D. J Rheumatol; 2002 Dec 17; 29(12):2555-7. PubMed ID: 12465151 [Abstract] [Full Text] [Related]
10. Antibody response to influenza vaccination in healthy adults. Brydak LB, Tadeusz S, Magdalena M. Viral Immunol; 2004 Dec 17; 17(4):609-15. PubMed ID: 15671759 [Abstract] [Full Text] [Related]
11. Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors. Bektas O, Karadeniz C, Oguz A, Berberoglu S, Yilmaz N, Citak C. Pediatr Blood Cancer; 2007 Dec 17; 49(7):914-7. PubMed ID: 17262793 [Abstract] [Full Text] [Related]
12. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Pediatrics; 1996 Aug 17; 98(2 Pt 1):196-200. PubMed ID: 8692617 [Abstract] [Full Text] [Related]
13. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly. Lina B, Fletcher MA, Valette M, Saliou P, Aymard M. Biologicals; 2000 Jun 17; 28(2):95-103. PubMed ID: 10885616 [Abstract] [Full Text] [Related]
14. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O. Ann Rheum Dis; 2008 Jul 17; 67(7):937-41. PubMed ID: 17981914 [Abstract] [Full Text] [Related]
15. Influenza vaccination of patients with systemic lupus erythematosus. Mercado U, Acosta H, Avendaño L. Rev Invest Clin; 2004 Jul 17; 56(1):16-20. PubMed ID: 15144037 [Abstract] [Full Text] [Related]
16. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers. de Bruijn IA, Nauta J, Gerez L, Palache AM. Virus Res; 2004 Jul 17; 103(1-2):139-45. PubMed ID: 15163502 [Abstract] [Full Text] [Related]
17. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951 [Abstract] [Full Text] [Related]
18. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2009 May 22; 58(19):521-4. PubMed ID: 19478718 [Abstract] [Full Text] [Related]
19. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. Iorio AM, Camilloni B, Basileo M, Neri M, Lepri E, Spighi M. Gerontology; 2007 May 22; 53(6):411-8. PubMed ID: 17975317 [Abstract] [Full Text] [Related]
20. Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China. Zhu FC, Zhou W, Pan H, Lu L, Gerez L, Nauta J, Giezeman K, de Bruijn I. Vaccine; 2008 Aug 18; 26(35):4579-84. PubMed ID: 18602729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]